Ingenuity canonical pathways that are included in the top 50 pathways in both PAE and Sac rats |
−log(p-value), minor nerve injury vs. sham surgery in PAE rats |
−log(p-value), minor nerve injury vs. sham surgery in Sac rats |
Synaptogenesis signaling pathway |
16 |
9.58 |
Protein kinase A signaling |
11.7 |
4.42 |
Opioid signaling pathway |
10.1 |
4.53 |
Neuropathic pain signaling in dorsal horn neurons |
6.05 |
3 |
Circadian rhythm signaling |
9.14 |
2.76 |
cAMP-mediated signaling |
6.7 |
3.04 |
Amyotrophic lateral sclerosis signaling |
10.3 |
6.77 |
Gap junction signaling |
4.64 |
4 |
TR/RXR activation |
7.44 |
6.56 |
Dopamine-DARPP32 feedback in cAMP signaling |
9.45 |
4.89 |
Insulin secretion signaling pathway |
5.66 |
3.45 |
Calcium signaling |
10.8 |
4.81 |
CLEAR signaling pathway |
5.6 |
4.85 |
Glutamate receptor signaling |
8.58 |
3.94 |
Myelination signaling pathway |
5.35 |
3.1 |
Synaptic long-term potentiation |
7.62 |
4.67 |
Autophagy |
6.17 |
5.46 |
Adrenomedullin signaling pathway |
4.17 |
3.5 |
Molecular mechanisms of cancer |
5.64 |
4.39 |
NGF signaling |
4.32 |
2.89 |
Oxytocin signaling pathway |
5.29 |
3.63 |
IL-15 production |
6.39 |
3.87 |
Sphingosine-1-phosphate signaling |
4.32 |
3.42 |
PPARα/RXRα activation |
4.32 |
6.23 |
Endocannabinoid neuronal synapse pathway |
8.92 |
5.76 |
Synaptic long-term depression |
7.05 |
2.66 |
Estrogen receptor signaling |
6.9 |
4.85 |
Huntington’s disease signaling |
5.67 |
4.46 |
Axonal guidance signaling |
5.39 |
4.02 |
SNARE signaling pathway |
5.06 |
3.41 |
RAR activation |
4.8 |
4.78 |
Senescence pathway |
4.36 |
2.9 |
Ephrin A signaling |
4.29 |
3.62 |